Prostate drug tested in women to prevent Post-Surgery urinary blockage

NCT ID NCT04232683

Completed Prevention Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early-phase trial tested whether giving tamsulosin (a drug typically used for prostate issues) before pelvic floor surgery in women could prevent postoperative urinary retention. 100 women undergoing surgery for prolapse, with or without a sling procedure, were enrolled. The study compared tamsulosin to a placebo to see if it helped them pass a voiding trial after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tamsulosin
What this could lead to: If it works, this could offer a simple way to prevent a common complication after pelvic surgery in women.
What could go wrong: This is a very early, small trial (100 women) with limited evidence. The drug may not work better than placebo, and side effects like low blood pressure are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY RETENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

URINARY RETENTION

Contacts and locations

Locations

Cleveland Clinic Florida

Weston, Florida, 33331, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.